Euda Health Holdings Subsidiary Reports Sharp Decrease in Net Loss and Improved EPS for H1 2025

Reuters
Oct 02
<a href="https://laohu8.com/S/EUDAW">Euda Health</a> Holdings Subsidiary Reports Sharp Decrease in Net Loss and Improved EPS for H1 2025

A subsidiary of EUDA Health Holdings Ltd. reported its financial results for the six months ended June 30, 2024. The subsidiary recorded revenue from external customers of $1,908,048 for the period, compared to no reported revenue in the same period of the previous year. The cost of revenue was $1,465,976, resulting in a segment gross profit of $442,072. The subsidiary reported a net loss of $16,748,274 for the six-month period, reflecting a substantial increase compared to a net loss of $1,201,696 in the same period of the prior year. The comprehensive loss for the period was $16,793,161, up from $1,176,581 in the previous year's comparable period. No significant updates regarding business operations were disclosed in the reported results.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Euda Health Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-016547), on October 01, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10